IP Library › Granted Patent US 10,098,379
Granted Patent B2
US 10,098,379 · App. 14/133,163 · Granted Oct 16, 2018

Device and method for simulating chemosensation of smoking

Inventors: Reid von Borstel (Potomac, MD); Dennis Tan (Weddington, NC); John Siverling (Matthews, NC); Inna S. Timokhina (Potomac, MD)
Assignee: Sentiens, LLC
A24D1/18A24B15/16A24B15/167A24F47/002A61M15/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,098,379
App. No.
14/133,163
Granted
Oct 16, 2018
Kind
B2
Abstract

A device for simulating a chemosenzation of smoking includes an outer layer, a porous medium and a chemesthetic agent. The porous medium is disposed within the outer layer. The chemesthetic agent is disposed within the porous medium and activates a TRP channel.

Claims (63)

1. A device for simulating a chemosensation of smoking, comprising:

a chemesthetic agent that activates a TRP channel, the chemesthetic agent including at least one of Zingiberaceae extract, Brassicaceae extract, Toddalioidae extract and Lamiaceae extract; and

an atomizer configured to volatize the chemesthetic agent, wherein

the agent is disposed in a propylene glycol based solution, and

the propylene glycol based solution includes a stabilizing constituent that includes at least one of a Benzoin resin from the Styracaceae family, sandalwood, red cedarwood, vetiver, orris root, oakmoss and myrrh.

2. The device according to claim 1 , wherein the glycol based solution includes ethanol.

3. The device according to claim 1 , wherein the TRP channel is a TRP receptor that imparts a chemesthetic sensation.

4. The device according to claim 1 , wherein the device is sized and shaped to mimic a cigarette.

5. The device according to claim 1 , wherein the agent is a volatile agent.

6. The device according to claim 1 , wherein the TRP channel is one or more of TRPV1, TRPA1, TRPV3 and TRPM8.

7. The device according to claim 1 , wherein the agent includes Zingiberaceae extract.

8. The device according to claim 1 , wherein the agent includes Brassicaceae extract.

9. The device according to claim 1 , wherein the agent includes Toddalioidae extract.

10. The device according to claim 1 , wherein the agent includes Lamiaceae extract.

11. The device according to claim 1 , wherein the agent includes at least one of the following:

approximately 5-10% by weight Szechuan pepper extract, 5-10% by weight mustard seed extract, approximately 5-10% by weight allspice extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 30-50% by weight galangal extract, approximately 5-10% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution;

approximately 15-25% by weight Szechuan pepper extract, approximately 15-25% by weight mustard extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 15-25% by weight galangal extract, approximately 10-15% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution; and

approximately 15-25% by weight Szechuan pepper extract, approximately 5-10% by weight mustard extract, approximately 5-10% allspice extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 15-25% by weight galangal extract, approximately 10-15% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution.

12. The device according to claim 1 , wherein the agent includes approximately 10-15% by weight benzoin resin extract.

13. A device for simulating a chemosensation of smoking, comprising:

a chemesthetic agent that activates a TRP channel disposed within the porous medium, the chemesthetic agent including at least one of 6-paradol, isothiocyanate, hydroxy-α-sanshool, 1′-acetoxychavicol, camphor, eugenol and thymol; and

an atomizer configured to volatize the chemesthetic agent, wherein

the agent is disposed in a propylene glycol based solution, and

the propylene glycol based solution includes a stabilizing constituent that includes at least one of a Benzoin resin from the Styracaceae family, sandalwood, red cedarwood, vetiver, orris root, oakmoss and myrrh.

14. The device according to claim 13 , wherein the propylene glycol based solution includes ethanol.

15. The device according to claim 13 , wherein the agent activates a TRP channel that is a TRP receptor that imparts a chemesthetic sensation.

16. The device according to claim 13 , wherein the TRP channel is one or more of TRPV1, TRPA1, TRPV3 and TRPM8.

17. The device according to claim 13 , wherein the agent includes 6-paradol.

18. The device according to claim 13 , wherein the agent includes 1′-acetoxychavicol.

19. The device according to claim 13 , wherein the agent includes isothiocyanate.

20. The device according to claim 13 , wherein the agent includes hydroxy-α-asanshool.

21. The device according to claim 13 , wherein the agent includes camphor.

22. The device according to claim 13 , wherein the agent includes thymol.

23. The device according to claim 13 , wherein the agent includes at least one of the following:

approximately 5-10% by volume hydroxy-α-sanshool solution, 5-10% by volume isothiocyanates solution, approximately 5-10% by volume eugenol solution, approximately 15-25% by volume 6-paradol solution, approximately 30-50% by volume 1′-acetoxychavicol solution, approximately 5-10% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution;

approximately 15-25% by volume hydroxy-α-sanshool solution, approximately 15-25% by volume isothiocyanate solution, approximately 15-25% by volume 6-paradol solution, approximately 15-25% by volume 1′-acetoxychavicol solution, approximately 10-15% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution; and

approximately 15-25% by volume hydroxy-α-sanshool solution, approximately 5-10% by volume isothiocyanate solution, approximately 5-10% by volume eugenol solution, approximately 15-25% by volume 6-paradol solution, approximately 15-25% 1′-acetoxychavicol solution, approximately 10-15% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution.

24. The device according to claim 13 , wherein the agent includes a stabilizing constituent of approximately 5-15% by volume.

25. A composition for simulating a chemosensation of smoking, comprising:

a chemesthetic agent that activates a TRP channel disposed in a propylene glycol based solution, the chemesthetic agent including at least one of Zingiberaceae extract, Brassicaceae extract, Toddalioidae extract, Lamiaceae extract, 6-paradol, isothiocyanate, hydroxy-α-sanshool, 1′-acetoxychavicol, camphor, eugenol and thymol, wherein

the agent includes approximately 10-15% by weight benzoin resin extract, and

the propylene glycol based solution includes a stabilizing constituent that includes at least one of a Benzoin resin from the Styracaceae family, sandalwood, red cedarwood, vetiver, orris root, oakmoss and myrrh.

26. The composition according to claim 25 , wherein the glycol based solution includes ethanol.

27. The composition according to claim 25 , wherein the TRP channel is a TRP receptor that imparts a chemesthetic sensation.

28. The composition according to claim 25 , wherein the agent is a volatile agent.

29. The composition according to claim 25 , wherein the TRP channel is one or more of TRPV1, TRPA1, TRPV3 and TRPM8.

30. The composition according to claim 25 , wherein the agent includes Zingiberaceae extract.

31. The composition according to claim 25 , wherein the agent includes Brassicaceae extract.

32. The composition according to claim 25 , wherein the agent includes Toddalioidae extract.

33. The composition according to claim 25 , wherein the agent includes Lamiaceae extract.

34. The composition according to claim 25 , wherein the agent includes 6-paradol.

35. The composition according to claim 25 , wherein the agent includes 1′-acetoxychavicol.

36. The composition according to claim 25 , wherein the agent includes isothiocyanate.

37. The composition according to claim 25 , wherein the agent includes hydroxy-α-sanshool.

38. The composition according to claim 25 , wherein the agent includes camphor.

39. The composition according to claim 25 , wherein the agent includes thymol.

40. The composition according to claim 25 , wherein the agent includes at least one of the following:

approximately 5-10% by weight Szechuan pepper extract, 5-10% by weight mustard seed extract, approximately 5-10% by weight allspice extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 30-50% by weight galangal extract, approximately 5-10% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution;

approximately 15-25% by weight Szechuan pepper extract, approximately 15-25% by weight mustard extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 15-25% by weight galangal extract, approximately 10-15% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution;

approximately 15-25% by weight Szechuan pepper extract, approximately 5-10% by weight mustard extract, approximately 5-10% allspice extract, approximately 15-25% by weight Aframomum Melegueta extract, approximately 15-25% by weight galangal extract, approximately 10-15% by weight rosemary extract, and approximately 0.2-0.4% by volume thymol solution;

approximately 5-10% by volume hydroxy-α-sanshool solution, 5-10% by volume isothiocyanates solution, approximately 5-10% by volume eugenol solution, approximately 15-25% by volume 6-paradol solution, approximately 30-50% by volume 1′-acetoxychavicol solution, approximately 5-10% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution;

approximately 15-25% by volume hydroxy-α-sanshool solution, approximately 15-25% by volume isothiocyanate solution, approximately 15-25% by volume 6-paradol solution, approximately 15-25% by volume 1′-acetoxychavicol solution, approximately 10-15% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution; and

approximately 15-25% by volume hydroxy-α-sanshool solution, approximately 5-10% by volume isothiocyanate solution, approximately 5-10% by volume eugenol solution, approximately 15-25% by volume 6-paradol solution, approximately 15-25% 1′-acetoxychavicol solution, approximately 10-15% by volume camphor solution, and approximately 0.2-0.4% by volume thymol solution.

Continuity (4)
Continuation 13710801 · Dec 11, 2012
Provisional Application 61570660 · Dec 14, 2011
Provisional Application 61651184 · May 24, 2012
Related Publication 20140102464A1 · Apr 17, 2014